Saturday 17 October 2026 Export BRTX’s income statement to Excel — free account

Biorestorative Therapies, Inc.

Biorestorative Therapies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $359,700.00, down 10.3% from fiscal 2024. In the quarter to March 2026, revenue fell 7.20%, EPS grew 81.3% and free cash flow fell 35.3%, each against the same quarter a year earlier.

1.54 0.08 +5.48%

Follow BRTX

Alert me

Market cap: $2.0M
P/E: 0.0×
Fwd P/E: −0.8×
Dividend yield: —
F-score: 4/9
Altman Z: −70.97
Beneish M: −7.56
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '25	Sep '25	Dec '25	Mar '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1.21	1.72	1.48	0.67
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(0.27)	(0.23)	(0.22)	(0.06)
P/B ratio Full definition →		0.15	0.30	1.55	0.08
Price to Tangible BV Full definition →		0.17	0.40	0.00	0.10
EV/Sales Full definition →		(10.67)	(9.49)	(6.20)	(8.83)
EV/EBITDA Full definition →		0.50	0.25	0.14	0.23
EV/Operating CF Full definition →		0.68	0.34	0.21	0.27
EV/FCF Full definition →		0.60	0.30	0.18	0.24
Quick Ratio Full definition →		2.01	1.31	0.80	2.23
Current Ratio Full definition →		2.07	1.37	0.84	2.35
Net Debt/EBITDA Full definition →		2.27	1.23	0.78	1.08
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.05	0.04	0.04	0.05
Operating CF/Net income Full definition →		1.01	0.95	0.75	1.77
Capex/Depreciation Full definition →		0.00	0.00	(1.51)	0.00
Interest Coverage Full definition →		44.73	—	41.72	615.58
Research and Development Expense of Revenue Full definition →		733.89%	21,989.83%	13,403.57%	8,303.02%
Selling, General and Administrative Expense of Revenue Full definition →		453.02%	9,453.39%	6,204.59%	6,358.62%
Intangible Assets out of Total Assets Full definition →		0.07	0.10	0.13	0.11
Share Based Compensation of Revenue Full definition →		154.53%	3,389.83%	2,284.69%	1,250.86%
Graham Net Nets Full definition →		5.38	1.92	(1.10)	9.13
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(1,520.96%)	(2,027.59%)	(2,694.92%)	(7,925.93%)
Free Cash Flow Yield Full definition →		(1,480.21%)	(1,807.42%)	(2,276.49%)	(5,477.46%)
Revenue per Share Full definition →		0.69	0.03	0.04	0.03
Operating CF per Share Full definition →		(6.16)	(6.36)	(5.37)	(4.30)
Capex per Share Full definition →		0.00	0.00	(0.18)	0.00
Free Cash Flow per Share Full definition →		(6.16)	(6.36)	(5.55)	(4.30)
Cash per Share Full definition →		16.89	9.85	6.57	4.05
Shareholders Equity per Share Full definition →		11.09	4.84	0.79	3.41
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		11.09	4.84	0.79	3.41
Free Cash Flow Full definition →		(2.69)	(2.90)	(2.49)	(3.81)
Working Capital Full definition →		3.93	1.27	(0.59)	2.19
Capital Expenditures Full definition →		0.00	0.00	(0.08)	—
Net Current Asset Value Full definition →		3.93	1.27	(0.59)	2.19
EV/EBIT Full definition →		0.49	0.25	0.14	0.22
Capex to Sales Full definition →		0.00	0.00	4.07	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		0.02	0.09	0.10	0.02
Average Payables Full definition →		0.41	0.63	0.91	0.63
Average Assets Full definition →		12.32	10.11	8.18	7.48
Average Common Equity Full definition →		7.81	6.09	4.43	4.58

Show all line items

Columns are period end dates

Stockrow Weekly